  |
 | Up a level |
Cristofanilli, Massimo and Rugo, Hope S. and Im, Seock-Ah and Slamon, Dennis J. and Harbeck, Nadia and Bondarenko, Igor and Masuda, Norikazu and Colleoni, Marco and DeMichele, Angela and Loi, Sherene and Iwata, Hiroji and O’Leary, Ben and André, Fabrice and Loibl, Sibylle and Bananis, Eustratios and Liu, Yuan and Huang, Xin and Sindy Kim, Sindy Kim and Frean, Maria Jose Lechuga and Turner, Nicholas C. (2022) Overall Survival With Palbociclib And Fulvestrant in Women With HR+/HER2– ABC: Updated Exploratory Analyses of PALOMA-3, a Double-Blind, Phase 3 Randomized Study. Clinical Cancer Research, 28 (16). pp. 3433-3442. ISSN 1078-0432 (print), 1557-3265 ( online)
Cristofanilli, Massimo and Rugo, Hope S. and Im, Seock-Ah and Slamon, Dennis J. and Harbeck, Nadia and Bondarenko, Igor and Masuda, Norikazu and Colleoni, Marco and DeMichele, Angela and Loi, Sherene and Iwata, Hiroji and O’Leary, Ben and André, Fabrice and Loibl, Sibylle and Bananis, Eustratios and Yuan Liu, Yuan Liu and Huang, Xin and Kim, Sindy and Frean, Maria Jose Lechuga and Turner, Nicholas C. (2022) Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2− ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study. Clinical Cancer Research, 28 (16). pp. 3433-3442. ISSN 1078-0432 (print), 1557-3265 ( online)
Byers, Lauren Averett and Navarro, Alejandro and Schaefer, Eric and Johnson, Melissa and Özgüroglu, Mustafa and Han, Ji-Youn and Bondarenko, Igor and Cicin, Irfan and Dragnev, Konstantin H. and Abel, Adam and Wang, Xuejing and McNeely, Samuel and Hynes, Scott and Lin, Aimee Bence and Forster, Martin (2021) A Phase II Trial of Prexasertib (LY2606368) in Patients With Extensive-Stage Small-Cell Lung Cancer. Clinical Lung Cancer, 000 (000). pp. 1-10. ISSN 1525-7304 (print), 1938-0690 (online)
Daniel, Davey and Kuchava, Vladimer and Bondarenko, Igor and Ivashchuk, Oleksandr and Reddy, Sreekanth and Jaal, Jana and Kudaba, Iveta and Hart, Lowell and Matitashvili, Amiran and Pritchett, Yili and Morris, Shannon R. and Sorrentino, Jessica A. and Antal, Joyce M. and Goldschmidt, Jerome (2021) Trilaciclib prior to chemotherapy and atezolizumab in patients with newly diagnosed extensive-stage small cell lung cancer: A multicentre, randomised, double-blind, placebo-controlled Phase II trial. International Journal of Cancer, V. 148 (Is. 10). pp. 2557-2570. ISSN 0020-7136 (print); 1097-0215 (online)
Recka, Martin and Luft, Alexander and Bondarenko, Igor and Shevnia, Serhii and Trukhin, Dmytro and Kovalenko, Nadezhda V. and Vacharadze, Kakha and Andrea, Fülöp and Hontsa, Anatoliy and Choi, Jihye and Shin, Donghoon (2020) A phase III, randomized, double-blind, multicenter study to compare the efficacy, safety, pharmacokinetics, and immunogenicity between SB8 (proposed bevacizumab biosimilar) and reference bevacizumab in patients with metastatic or recurrent nonsquamous non-small cell lung cancer. Lung Cancer, V. 146. pp. 12-18. ISSN 0169-5002
Reinmuth, Niels and Paz-Ares, Luis and Chen, Yuanbin and Hotta, Katsuyuki and Trukhin, Dmytro and Statsenko, Galina and Hochmair, Maximilian J and Özgüroğlu, Mustafa and LI, Jun Ho and Voitko, Oleksandr and Poltoratskiy, Artem and Ponce, Santiago and Verderame, Francesco and Havel, Libor and Bondarenko, Igor and Kazarnowicz, Andrzej and Losonczy, György and Conev, Nicolay V and Armstrong, Jon and Byrne, Natalie and Shire, Norah and Jiang, Haiyi and Goldman, Jonathan and Alt, Jürgen (2020) Caspian: Os Results from a Randomised Phase 3 Study of First-Line Durvalumab ± Tremelimumab + Chemotherapy in ES-SCLC. Oncology Research and Treatment, V. 43 (s. 1). p. 115. ISSN 2296-5270 (Print); 2296-5262 (Online)
Finn, Richard S. and Boer, Katalin and Bondarenko, Igor and Patel, Ravindranath and Pinter, Tamas and Schmidt, Marcus and Shparyk, Yaroslav V. and Thummala, Anu and Voitko, Nataliia and Bananis, Eustratios and McRoy, Lynn and Wilner, Keith and Huang, Xin and Kim, Sindy and Slamon, Dennis J. and Ettl, Johannes (2020) Overall survival results from the randomized phase 2 study of palbociclib in combination with letrozole versus letrozole alone for first‑line treatment of ER+/HER2− advanced breast cancer (PALOMA‑1, TRIO‑18). Breast Cancer Research and Treatment, 183. pp. 419-428. ISSN 0167-6806 (print); 1573-7217 (online)
Pivot, Xavier and Pegram, Mark and Cortes, Javier and Luftner, Diana and Lyman, Gary H. and Curigliano, Giuseppe and Bondarenko, Igor and Ye Chan Yoon and Kim, Younsoo and Kim, Chul (2019) Three-year follow-up from a phase 3 study of SB3 (a trastuzumab biosimilar) versus reference trastuzumab in the neoadjuvant setting for human epidermal growthfactor receptor 2-positive breast cancer. European Journal of Cancer, V. 120. pp. 1-9. ISSN 0959-8049
Shparyk, Yaroslav V. and Bondarenko, Igor and Paravisini, Alexandra and Florez, Amalia and Huerga, Camino and Abad, Marta and Bullo, Felicitas and Millan, Susana (2019) Bevacizumab biosimilar and reference bevacizumab in subjects with stage IIIB/IV non-squamous non-small cell lung cancer (STELLA): Design of a confirmatory, double-blind, randomized, controlled study. Journal of Clinical Oncology, 37 (15supp). e20731-e20731. ISSN 1527-7755 (online, version of record) and 0732-183X (print)
Kahan, Zsuzsanna and Grecea, Daniela and Smakal, Martin and Tjulandin, Sergei and Bondarenko, Igor and Perjesi, Luca and Illes, Andras and Horvat-Karajz, Karoly and Aradi, Ildiko (2019) Efficacy and safety of RGB-02, a pegfilgrastim biosimilar to prevent chemotherapy-induced neutropenia: results of a randomized, double-blind phase III clinical study vs. reference pegfilgrastim in patients with breast cancer receiving chemotherapy. BMC Cancer, Vol.19. p. 122. ISSN 1471-2407
Nathan, Paul D. and Robert, Caroline and Grob, Jean Jacques and Stroyakovskiy, Daniil and Karaszewska, Boguslawa and Hauschild, Axel and Levchenko, Eugeny and Sileni, Vanna Chiarion and Schachter, Jacob and Garbe, Claus and Bondarenko, Igor and Davies, Michael A. and Ribas, Antoni and Flaherty, Keith and Burgess, Paul and Tan, Monique and Gasal, Eduard and Schadendorf, Dirk and Georgina V. (2019) Five-year analysis on the long-term effects of dabrafenib plus trametinib (D + T) in patients with BRAF V600–mutant unresectable or metastatic melanoma. Journal of Clinical Oncology, 37 (15supp). p. 9507. ISSN 1527-7755 (online, version of record) and 0732-183X (print)
Schadendorf, Dirk and Di Giacomo, Anna Maria and Demidov, Lev and Merelli, Barbara and Bondarenko, Igor and Ascierto, Paolo A. and Herbert, Christopher and Mackiewicz, Andrzej and Rutkowski, Piotr and Guminski, Alexander and Goodman, Grant R. and Simmons, Brian and Ye, Chenglin and Hong, Agnes and Lewis, Karl and the BRIM8 Investigators (2019) Health-related quality of life in patients with fully resected BRAFV600 mutation–positive melanoma receiving adjuvant vemurafenib. European Journal of Cancer, V.123. pp. 155-161. ISSN 0959-8049
Pegram, Mark D. and Bondarenko, Igor and Zorzetto, Marina Moreira Costa and Hingmire, Sachin and Iwase, Hirotaka and Krivorotko, Petr V. and Lee, Keun Seok and Li, Rubi K. and Pikiel, Joanna and Aggarwal, Rajesh and Ewesuedo, Reginald and Freyman, Amy and Li, Ray and Vana, Alicia and Yin, Donghua and Zacharchuk, Charles and Tan-Chiu, Elizabeth (2019) PF-05280014 (a trastuzumab biosimilar) plus paclitaxel compared with reference trastuzumab plus paclitaxel for HER2-positive metastatic breast cancer: a randomised, double-blind study. British Journal of Cancer, 120. pp. 172-182. ISSN 0007-0920 (print), 1532-1827 (online)
Reinmuth, Niels and Bryl, Maciej and Bondarenko, Igor and Syrigos, Kostas and Vladimirov, Vladimir and Zereu, Manuela and Bair, Angel H. and Hilton, Fiona and Liau, Katherine and Kasahara, Kazuo (2019) PF‑06439535 (a Bevacizumab Biosimilar) Compared with Reference Bevacizumab (Avastin®), Both Plus Paclitaxel and Carboplatin, as First‑Line Treatment for Advanced Non‑Squamous Non‑Small‑Cell Lung Cancer: A Randomized, Double‑Blind Study. BioDrugs. pp. 1-16. ISSN 1173-8804 (Print) 1179-190X (Online)
Hojouj, Mohammad IM and Bondarenko, Igor and Zavizion, Viktor and Maltseva, Liebov and Elhaj, Mohamad and Hurtovyi, Vadym and Hojouj, Tamara and Tereshchenko, Pavlo and Tereshchenko, Sergii (2019) A Rare Case of Sezary Syndrome Cutaneous T-Cell Lymphoma with Complete Response. Journal of Biotechnology & Bioresearch, Vol. 2 (Iss. 2). pp. 1-3. ISSN 2643-704X
Dang, Nam H. and Ogura, Michinori and Castaigne, Sylvie and Fayad, Luis E. and Jerkeman, Mats and Radford, John and Antonio, Antonio and Bondarenko, Igor and Stewart, Douglas A and Shnaidman, Michael and Sullivan, DR. Sharon and Vandendries, Erik and Tobinai, Kensei and Ramchandren, Radhakrishnan and Hamlin, Paul A. and Giné, Eva and Ando, Kiyoshi (2018) Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/ refractory aggressive B-cell non-Hodgkin lymphoma. British Journal of Haematology, 182 (4). pp. 583-586. ISSN 1365-2141
Finn, Richard S. and Crown, John and Lang, Istvan and Boer, Katalin and Bondarenko, Igor and Kulyk, Sergey O. and Ettl, Johannes and Patel, Ravindranath and Pinter, Tamas and Schmidt, Marcus and Shparyk, Yaroslav V. and Thummala, Anu and Voytko, Nataliya L. and Fowst, Camilla and Huang, Xin and Kim, Sindy and Slamon, Dennis J. (2017) Overall survival results from the randomized phase II study of palbociclib (P) in combination with letrozole (L) vs letrozole alone for frontline treatment of ER+/HER2–advanced breast cancer (PALOMA-1; TRIO-18). Journal of Clinical Oncology, 35 (15). p. 1001. ISSN 0732-183X (Print) ; 1527-7755 (Electronic) ; 0732-183X (Linking)
Pivot, Xavier B and Bondarenko, Igor and Dvorkin, Mikhail and Trishkina, Ekaterina and Ahn, Jin-Hee and Im, Seock-Ah and Sarosiek, Tomasz and Chattopadhyay, Sanjay and Wojtukiewicz, Marek and Moiseyenko, Vladimir and Shparyk, Yaroslav V and Bello, Maximino De Guzman and Semiglazov, Vladimir and Song, Sujeong and Lim, Jae Yun (2017) A randomized, double-blind, phase III study comparing SB3 (trastuzumab biosimilar) with originator trastuzumab in patients treated by neoadjuvant therapy for HER2-positive early breast cancer. Journal of Clinical Oncology, 35 (15). p. 509. ISSN 0732-183X (Print) ; 1527-7755 (Electronic) ; 0732-183X (Linking)
Rugo, Hope S. and Barve, Abhijit and Waller, Cornelius F. and Hernandez-Bronchud, Miguel and Herson, Jay and Yuan, Jinyu and Sharma, Rajiv and Baczkowski, Mark and Kothekar, Mudgal and Loganathan, Subramanian and Manikhas, Alexey and Bondarenko, Igor and Mukhametshina, Guzel and Nemsadze, Gia and Parra, Joseph D and Abesamis Tiambeng, Maria Luisa T. and Baramidze, Kakhaber and Akewanlop, Charuwan and Vynnychenko, Ihor and Sriuranpong, Virote and Mamillapalli, Gopichand and Ray, Sirshendu and Ruiz, Eduardo P Yanez and Pennella, Eduardo (2017) Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)–Positive Metastatic Breast Cancer. A Randomized Clinical Trial. JAMA, 317 (1). pp. 37-47.
Miles, David and Cameron, David and Bondarenko, Igor and Manzyuk, Lyudmila and Alcedo, Juan Carlos and Lopez, Roberto Ivan and Im, Seock-Ah and Canon, Jean-Luc and Shparyk, Yaroslav and Yardley, Denise A and Masuda, Norikazu and Ro, Jungsil and Denduluri, Neelima and Hubeaux, Stanislas and Quah, Cheng and Bais, Carlos and O'Shaughnessy, Joyce (2017) Bevacizumab plus paclitaxel versus placebo plus paclitaxel as first-line therapy for HER2-negative metastatic breast cancer (MERiDiAN): A double-blind placebo-controlled randomised phase III trial with prospective biomarker evaluation. European journal of cancer, 70. pp. 146-155. ISSN 1879-0852
Karthaus, Meinolf and Fedyanin, Mikhail and Bondarenko, Igor and Chessari, Salvatore and Spezia, Riccardo and Giorgino, Ruben (2017) Elsiglutide in the primary prevention of chemotherapy (CT)-induced diarrhea in patients with colorectal cancer (CRC) receiving 5-fluorouracil (5-FU)-based CT: A multinational, randomized, double-blind, placebo-controlled study. Journal of Clinical Oncology, 35 (15). p. 10101. ISSN 0732-183X (Print) ; 1527-7755 (Electronic) ; 0732-183X (Linking)
Aapro, Matti and Karthaus, Meinolf and Schwartzberg, Lee and Bondarenko, Igor and Sarosiek, Tomasz and Oprean, Cristina and Cardona-Huerta, Servando and Hansen, Vincent and Rossi, Giorgia and Rizzi, Giada and Borroni, Maria Elisa and Rugo, Hope (2017) NEPA, a fixed oral combination of netupitant and palonosetron, improves control of chemotherapy-induced nausea and vomiting (CINV) over multiple cycles of chemotherapy: results of a randomized, double-blind, phase 3 trial versus oral palonosetron. Supportive Care in Cancer, 25 (4). pp. 1127-1135. ISSN 0941-4355 (Print) 1433-7339 (Online)
Bergqvist, Michael and Holgersson, Georg and Bondarenko, Igor and Grechanaya, Elena and Maximovich, Alexey and Andor, György and Klockare, Maria and Thureson, Marcus and Jerling, Markus and Harmenberg, Johan (2017) Phase II randomized study of the IGF-1R pathway modulator AXL1717 compared to docetaxel in patients with previously treated, locally advanced or metastatic non-small cell lung cancer. Acta Oncologica, Vol.56 (N 3). pp. 441-447. ISSN 0284-186X (Print) 1651-226X (Online)
Roca, Enrique Luis and Vinnyk, Yuriy and Bondarenko, Igor and Shparyk, Yaroslav V. and Bariani, Giovanni Mendonca and Abdalla, Kathia and Franke, Fábio and Cruz, Felipe and Romera, Alvaro and Bhamare, Sulabhchandra and Sudalaiandi, Suresh and Ostwal, Vikas S. and Shah, Pradeep and Rahuman, Sajeed and Cubillo, Antonio and Huerga, Camino and Alexandra, Paravisini and Fernandez, Francisco Javier and Millan, Susana (2017) Results of bevacizumab biosimilar compared with RMP for the treatment of metastatic colorectal cancer. Journal of Clinical Oncology, 35 (15). e14065-e14065. ISSN 0732-183X (Print) ; 1527-7755 (Electronic) ; 0732-183X (Linking)
Li, Weimin and O'Shaughnessy, Joyce and Hayes, Daniel and Campone, Mario and Bondarenko, Igor and Zbarskaya, Irina and Brain, Etienne and Stenina, Marina and Ivanova, Olga and Graas, Marie-Pascale and Neven, Patrick and Ricci, Deborah and Griffin, Thomas and Kheoh, Thian and Yu, Margaret and Gormley, Michael and Martin, Jason and Michael, Schaffer and Zelinsky, Kathy and De Porre, Peter and Johnston, Stephen R.D. (2016) Biomarker Associations with Efficacy of Abiraterone Acetate and Exemestane in Postmenopausal Patients with Estrogen Receptor–Positive Metastatic Breast Cancer. Clinical Cancer Research, 22 (24). pp. 6002-6009. ISSN 1078-0432 (print), 1557-3265 ( online)
Al-Batran, Salah-Eddin and Schuler, Martin H. and Zvirbule, Zanete and Manikhas, Georgiy and Lordick, Florian and Rusyn, Andriy and Vynnyk, Yuriy and Vynnychenko, Ihor and Fadeeva, Natalia and Nechaeva, Marina and Dudov, Assen and Gotovkin, Evgeny and Pecheniy, Alexander and Bazin, Igor and Bondarenko, Igor and Melichar, Bohuslav and Mueller, Christian and Huber, Christoph and Tureci, Oezlem and Sahin, Ugur (2016) FAST: An international, multicenter, randomized, phase II trial of epirubicin, oxaliplatin, and capecitabine (EOX) with or without IMAB362, a first-in-class anti-CLDN18.2 antibody, as first-line therapy in patients with advanced CLDN18.2+ gastric and gastroesophageal junction (GEJ) adenocarcinoma. Journal of Clinical Oncology, Vol 34 (No18_s). P.-LBA4001. ISSN 0732-183X (Print) ; 1527-7755 (Electronic) ; 0732-183X (Linking)
Volovat, Constantin and Bondarenko, Igor and Gladkov, Oleg and Buchner, Anton and Lammerich, Andreas and Müller, Udo and Bias, Peter (2016) Efficacy and safety of lipegfilgrastim compared with placebo in patients with non-small cell lung cancer receiving chemotherapy: post hoc analysis of elderly versus younger patients. Support Care Cancer, 24. pp. 4913-4920. ISSN 0941-4355
Rugo, Hope S. and Barve, Abhijit and Waller, Cornelius F. and Hernandez-Bronchud, Miguel and Herson, Jay and Yuan, Jinyu and Manikhas, Alexey and Bondarenko, Igor and Mukhametshina, Guzel and Nemsadze, Gia and Parra, Joseph D. and Tiambeng, Maria Luisa T. Abesamis and Baramidze, Kakhaber and Akewanlop, Charuwan and Vynnychenko, Ihor and Sriuranpong, Virote and Manillapalli, Gopichand and Ray, Sirshendu and Ruiz, Eduardo Patricio Yanez and Pennella, Eduardo J (2016) Heritage: A phase III safety and efficacy trial of the proposed trastuzumab biosimilar Myl-1401O versus Herceptin. Journal of Clinical Oncology, Vol 34 (18_sup). P.-LBA503. ISSN 0732-183X (Print) ; 1527-7755 (Electronic) ; 0732-183X (Linking)
Awada, Ahmad and Colomer, Ramon and Inoue, Kenichi and Bondarenko, Igor and Badwe, Rajendra A. and Demetriou, Georgia and Lee, Soo-Chin and Mehta, Ajay O. and Kim, Sung-Bae and Bachelot, Thomas and Goswami, Chanchal and Deo, Suryanarayan and Bose, Ron and Wong, Alvin and Xu, Feng and Yao, Bin and Bryce, Richard and Carey, Lisa A. (2016) Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial. JAMA Oncology, 2 (12). pp. 1557-1564. ISSN 2374-2437 (Print) ; 2374-2445 (Electronic) ; 2374-2437 (Linking)
Hawkins, Robert E. and Gore, Martin and Shparyk, Yaroslav and Bondar, Vladimir and Gladkov, Oleg and Ganev, Tosho and Harza, Mihai and Polenkov, Serhii and Bondarenko, Igor and Karlov, Petr and Karyakin, Oleg and Khasanov, Rustem and Hedlund, Gunnar and Forsberg, Goran and Nordle, Orjan and Eisen, Timothy (2016) A Randomized Phase II/III Study of Naptumomab Estafenatox + IFNα versus IFNα in Renal Cell Carcinoma: Final Analysis with Baseline Biomarker Subgroup and Trend Analysis. Clinical Cancer Research, 22 (13). pp. 3172-3181. ISSN 1078-0432 (print), 1557-3265 ( online)
Novello, Silvia and Kaiser, Rolf and Mellemgaard, Anders and Douillard, Jean-Yves and Orlov, Sergey and Krzakowski, Maciej and von Pawel, Joachim and Gottfried, Maya and Bondarenko, Igor and Liao, Meilin and Barrueco, Jose and Gaschler-Markefski, Birgit and Griebsch, Ingolf and Palmer, Michael and Reck, Martin (2015) Analysis of patient-reported outcomes from the LUME-Lung 1 trial: A randomised, double-blind, placebo-controlled, Phase III study of second-line nintedanib in patients with advanced non-small cell lung cancer. European Journal of Cancer, V. 51 (Iss. 3). pp. 317-326. ISSN 0959-8049
Eisen, Tim and Shparyk, Yaroslav and Macleod, Nicholas and Jones, Robert and Wallenstein, Gudrun and Temple, Graham and Khder, Yasser and Dallinger, Claudia and Studeny, Matus and Loembe, Arsene-Bienvenu and Bondarenko, Igor (2013) Effect of small angiokinase inhibitor nintedanib (BIBF 1120) on QT interval in patients with previously untreated, advanced renal cell cancer in an open-label, phase II study. Investigational New Drugs, Vol.31 (Iss 5). pp. 1283-1293. ISSN 0167-6997 (Print) 1573-0646 (Online)
Aseyev, Olexiy and Bondarenko, Igor and Mohammad El Hajj and Zavizion, Viktor and Kunnik, Anna (2013) Factors affecting changes in immunohistochemistry phenotype of breast cancer. The Breast, 22 (S3). S60. ISSN 0960-9776
Karamlou, Tara and Poynter, Jeffrey A. and Walters, Henry L. and Rhodes, Jonathan and Bondarenko, Igor and Pasquali, Sara K. and Fuller, Stephanie M. and Lambert, Linda M. and Blackstone, Eugene H. and Jacobs, Marshall L. and Duncan, Kim and Caldarone, Christopher A. and Williams, William G. and McCrindle, Brian W. (2013) Long-term functional health status and exercise test variables for patients with pulmonary atresia with intact ventricular septum: A Congenital Heart Surgeons Society study. The Journal of Thoracic and Cardiovascular Surgery, V. 145 (N 4). pp. 1018-1027. ISSN 0022-5223
Robert, Caroline and Thomas, Luc and Bondarenko, Igor and O’Day, Steven and Weber, Jeffrey and Garbe, Claus and Lebbe, Celeste and Baurain, Jean-François and Testori, Alessandro and Grob, Jean-Jacques and Davidson, Neville and Richards, Jon and Maio, Michele and Hauschild, Axel and Miller, Wilson H. and Gascon, Pere and Lotem, Michal and Harmankaya, Kaan and Ibrahim, Ramy and Francis, Stephen and Chen, Tai-Tsang and Humphrey, Rachel and Hoos, Axel and Wolchok, Jedd D. (2011) Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma. The New England Journal of Medicine = N Engl J Med, 364. pp. 2517-2526. ISSN 0028-4793 (print); 1533-4406 (online)
